QUIDELORTHO CORP Operating Cash Flow
QUIDELORTHO CORP (QDEL) reported Operating Cash Flow of -$143.60 million for the 6-month period ending 2026-06-28, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-07
- QUIDELORTHO CORP net cash provided by (used in) operating activities for the quarter ending 2026-06-28 was -$110.60M.
- QUIDELORTHO CORP net cash provided by (used in) operating activities for the quarter ending 2026-03-29 was -$33.00M, a 150.30% decline year-over-year.
- QUIDELORTHO CORP net cash provided by (used in) operating activities for the quarter ending 2025-12-28 was $131.90M, a 107.06% increase year-over-year.
- QUIDELORTHO CORP net cash provided by (used in) operating activities for the quarter ending 2025-09-28 was -$45.50M, a 138.59% decline year-over-year.
- QUIDELORTHO CORP net cash provided by (used in) operating activities for fiscal 2025 was $105.20M, a 26.75% increase from fiscal 2024.
- QUIDELORTHO CORP net cash provided by (used in) operating activities for fiscal 2024 was $83.00M, a 70.38% decline from fiscal 2023.
- QUIDELORTHO CORP net cash provided by (used in) operating activities for fiscal 2023 was $280.20M, a 68.35% decline from fiscal 2023.
- QUIDELORTHO CORP net cash provided by (used in) operating activities for fiscal 2023 was $885.30M, a 9.85% increase from fiscal 2022.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-28 | -$110.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$143.60M 10-Q · filed 2026-08-07 | -$11.70M derived: sum of 3 quarters · filed 2026-08-07 | -$57.20M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-29 | -$33.00M 10-Q · filed 2026-05-06 | $98.90M derived: sum of 2 quarters · filed 2026-05-06 | $53.40M derived: sum of 3 quarters · filed 2026-05-06 | $6.60M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-28 | $131.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $86.40M derived: sum of 2 quarters · filed 2026-02-19 | $39.60M derived: sum of 3 quarters · filed 2026-08-07 | $105.20M 10-K · filed 2026-02-19 |
| 2025-09-28 | -$45.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$92.30M derived: sum of 2 quarters · filed 2026-08-07 | -$26.70M 10-Q · filed 2025-11-06 | $37.00M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-29 | -$46.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $18.80M 10-Q · filed 2026-08-07 | $82.50M derived: sum of 3 quarters · filed 2026-08-07 | $200.40M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-30 | $65.60M 10-Q · filed 2026-05-06 | $129.30M derived: sum of 2 quarters · filed 2026-05-06 | $247.20M derived: sum of 3 quarters · filed 2026-05-06 | $149.30M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-29 | $63.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $181.60M derived: sum of 2 quarters · filed 2026-02-19 | $83.70M derived: sum of 3 quarters · filed 2026-02-19 | $83.00M 10-K · filed 2026-02-19 |
| 2024-09-29 | $117.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $20.00M derived: sum of 2 quarters · filed 2025-11-06 | $19.30M 10-Q · filed 2025-11-06 | $99.70M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-06-30 | -$97.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$98.60M 10-Q · filed 2025-08-06 | -$18.20M derived: sum of 3 quarters · filed 2026-02-19 | $23.30M derived: sum of 4 quarters · filed 2026-02-19 |
| 2024-03-31 | -$700.00K 10-Q · filed 2025-05-08 | $79.70M derived: sum of 2 quarters · filed 2026-02-19 | $121.20M derived: sum of 3 quarters · filed 2026-02-19 | $90.60M derived: sum of 4 quarters · filed 2026-02-19 |
| 2023-12-31 | $80.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $121.90M derived: sum of 2 quarters · filed 2026-02-19 | $91.30M derived: sum of 3 quarters · filed 2026-02-19 | $280.20M 10-K · filed 2026-02-19 |
| 2023-10-01 | $41.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $10.90M derived: sum of 2 quarters · filed 2024-11-08 | $199.80M 10-Q · filed 2024-11-08 | $369.20M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-07-02 | -$30.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $158.30M 10-Q · filed 2024-08-01 | $327.70M derived: sum of 3 quarters · filed 2025-02-27 | $318.00M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-04-02 | $188.90M 10-Q · filed 2024-05-09 | $358.30M derived: sum of 2 quarters · filed 2025-02-27 | $348.60M derived: sum of 3 quarters · filed 2025-02-27 | $573.30M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-01-01 | $169.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $159.70M derived: sum of 2 quarters · filed 2025-02-27 | $384.40M derived: sum of 3 quarters · filed 2025-02-27 | $885.30M 10-K · filed 2025-02-27 |
| 2022-10-02 | -$9.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $215.00M derived: sum of 2 quarters · filed 2023-11-02 | $715.90M 10-Q · filed 2023-11-02 | $1.04B derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-07-03 | $224.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $725.60M 10-Q · filed 2023-08-09 | $1.05B derived: sum of 3 quarters · filed 2024-08-01 | $1.12B derived: sum of 4 quarters · filed 2024-08-01 |
| 2022-04-03 | $500.90M 10-Q · filed 2023-05-04 | $822.30M derived: sum of 2 quarters · filed 2024-08-01 | $899.30M derived: sum of 3 quarters · filed 2024-08-01 | |
| 2022-01-02 | $321.40M derived: 10-K/A 12 month − 10-Q 9 month · filed 2024-08-01 | $398.40M derived: sum of 2 quarters · filed 2024-08-01 | $805.90M 10-K/A · filed 2024-08-01 | |
| 2021-10-03 | $77.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $484.50M 10-Q · filed 2022-11-04 | ||
| 2021-07-04 | $407.50M 10-Q · filed 2022-08-05 | |||
| 2021-01-03 | $629.70M 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |